US 12,285,592 B2
Infusion devices and related methods and systems for preemptive alerting
Cesar C. Palerm, Pasadena, CA (US); and Jeffrey C. Myers, Moorpark, CA (US)
Assigned to MEDTRONIC MINIMED, INC., Northridge, CA (US)
Filed by MEDTRONIC MINIMED, INC., Northridge, CA (US)
Filed on Jun. 28, 2023, as Appl. No. 18/343,305.
Application 16/387,297 is a division of application No. 14/578,174, filed on Dec. 19, 2014, granted, now 10,307,535, issued on Jun. 4, 2019.
Application 18/343,305 is a continuation of application No. 17/457,165, filed on Dec. 1, 2021, granted, now 11,744,942.
Application 17/457,165 is a continuation of application No. 16/387,297, filed on Apr. 17, 2019, granted, now 11,191,896, issued on Dec. 7, 2021.
Prior Publication US 2023/0338651 A1, Oct. 26, 2023
Int. Cl. A61M 5/172 (2006.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61M 5/168 (2006.01); G16H 20/17 (2018.01)
CPC A61M 5/16831 (2013.01) [A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); A61B 5/7275 (2013.01); A61M 5/1723 (2013.01); G16H 20/17 (2018.01); A61M 2205/18 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A method for insulin therapy, the method comprising:
identifying an amount of future insulin deliveries to be delivered by an infusion device;
determining a homeostasis metric by predicting a change in a current glucose measurement value based on accounting for metabolism of a current amount of active insulin and the amount of future insulin deliveries; and
generating an alert based at least in part on the homeostasis metric.